NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Devito M, Farrell P, Hagiwara S, et al. Value of Information Case Study on the Human Health and Economic Trade-offs Associated with the Timeliness, Uncertainty, and Costs of the Draft EPA Transcriptomic Assessment Product (ETAP). Washington (DC): U.S. Environmental Protection Agency; 2024 Jul.
Value of Information Case Study on the Human Health and Economic Trade-offs Associated with the Timeliness, Uncertainty, and Costs of the Draft EPA Transcriptomic Assessment Product (ETAP).
Show detailsThe supplemental material includes VOI sensitivity results described via eight tables. Supplemental material can be accessed at https://doi.org/10.23645/epacomptox.26093572.v1 as an Excel spreadsheet with individual tables delimited via tabs. The ‘Read Me’ tab in the spreadsheet includes a copy of the table below.
| Table / Tab | Content |
|---|---|
| S 6.2.1 BRDM | Results of VOI sensitivity analysis evaluating the effect of quality of exposure information for BRDM |
| S 6.2.1 TRDM | Results of VOI sensitivity analysis evaluating the effect of quality of exposure information for TRDM |
| S 6.2.2 | Results of VOI sensitivity analysis evaluating the effect of adverse health outcome and cost of control for BRDM and TRDM |
| S 6.2.3 A | Results of VOI sensitivity analysis evaluating the effect of assessment duration for BRDM and TRDM |
| S 6.2.3 B | Results of VOI sensitivity analysis evaluating the effect of time horizon for BRDM and TRDM |
| S 6.2.3 C | Calculation of total benefits realized within a pre-specified time horizon |
| S 6.2.5 BRDM | BRDM Results of VOI sensitivity analysis evaluating the effect of affected population size for BRDM |
| S 6.2.5 TRDM | Results of VOI sensitivity analysis evaluating the effect of affected population size for TRDM |
- SUPPLEMENTAL MATERIAL - Value of Information Case Study on the Human Health and ...SUPPLEMENTAL MATERIAL - Value of Information Case Study on the Human Health and Economic Trade-offs Associated with the Timeliness, Uncertainty, and Costs of the Draft EPA Transcriptomic Assessment Product (ETAP)
Your browsing activity is empty.
Activity recording is turned off.
See more...